key: cord-0857217-b3ckr38i authors: Mboumba Bouassa, Ralph-Sydney; Veyer, David; Péré, Hélène; Bélec, Laurent title: Analytical performances of the point-of-care SIENNA™ COVID-19 Antigen Rapid Test for the detection of SARS‐CoV‐2 nucleocapsid protein in nasopharyngeal swabs: A prospective evaluation during the COVID-19 second wave in France date: 2021-03-18 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.03.051 sha: 1b503b7d753bfbb6a056c60afe62e09ce375dd40 doc_id: 857217 cord_uid: b3ckr38i Objectives We herein assessed the analytical performances of the antigen-rapid diagnosis test (Ag-RDT) SIENNA™ COVID-19 Antigen Rapid Test Cassette (Nasopharyngeal Swab) (Salofa Oy, Salo, Finland), targeting the SARS-CoV-2 N nucleocapsid protein, for the diagnosis of COVID‐19 in hospitalized patients with suspect SARS‐CoV‐2 infection, by reference to real-time RT-PCR (rRT-PCR). Methods Nasopharyngeal swabs were collected from patients with COVID-19-like illness during the second epidemic wave in Paris, France, among which 100 and 50 were positive and negative for RNA SARS-CoV-2, respectively. Results Overall, the Ag-RDT showed high sensitivity, specificity, positive and negative predictive values of 90.0%, 100.0%, 100.0% and 98.1%, respectively, as well as high or almost perfect agreement (93.3%), reliability assessed by Cohen's κ coefficient (0.86), and accuracy assessed by Youden’s J index (90%) to detect SARS-CoV-2. The analytical performances of the Ag-RDT remained high in the event of significant viral excretion (i.e., N gene Ct values ≤ 33 by reference rtRT-PCR), while the sensitivity of the Ag-RDT dropped to 69.6% with low or very low viral shedding (Ct> 33). Conclusions The SIENNA™ Ag-RDT presents excellent analytical performances for viral loads ≤ 33 Ct, classically corresponding to situations of symptomatic COVID-19 and/or proven contagiousness. The Coronavirus disease 2019 (COVID-19) pandemic continues to spread across the world. Hence, there is an urgent need for rapid, simple, and accurate tests to diagnose severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. While currently-recommended nucleic acid amplification tests (NAAT), such as real-time reverse transcription polymerase chain reaction (rtRT-PCR) assays, remain the gold-standard cornerstone for the diagnosis of SARS-CoV-2 infection (Dinnes et al., 2020) . Ag-RDT relies on direct detection of SARS-CoV-2 viral proteins produced by replicating virus in nasal swabs and other respiratory secretions, often the virus N nucleocapsid protein, preferred because of its relative abundance and conserved structure, or other viral proteins such as the spike protein (Li & Li, 2020) . Most Ag-RDTs use sandwich catching by anti-SARS-CoV-2 monoclonal antibodies to detect viral antigens in the simple-to-use lateral flow immunoassay format allowing results in < 30 minutes. Around 150 Ag-RDTs for SARS-CoV-2 infection are now commercially available or in development (FindDx, 2021) . However, there is significant variability reported with respect to their diagnostic performances and a lack of external validation for many of the available tests, which still require clinical validation (Dinnes et variables. The results were presented along with their 95% confidence interval (CI) using the Wilson score bounds for categorical variables (Newcombe, 1998) . The results of SARS-CoV-2 RNA detection by the multiplex rRT-PCR were used as the reference standard to estimate the sensitivity and specificity of the study Ag-RDT, with corresponding 95% CI. The concordance between study Ag-RDT and multiplex molecular detection of SARS-CoV-2 RNA was assessed by percent agreement corresponding to the observed proportion of identical results between Ag-RDT compared to rRT-PCR detection. The J o u r n a l P r e -p r o o f reliability between the study Ag-RDT and the multiplex molecular detection of SARS-CoV-2 RNA was estimated by Cohen's κ coefficient (Cohen, 1960) , and the degree of agreement was determined as ranked by Landlis and Koch (Landlis & Koch, 1977) . The accuracy of the study Ag-RDT to correctly diagnose SARS-CoV-2 infection was estimated by Youden's J index (J = sensitivity + specificity − 1) (Youden, 1950 The and 100.0%, specificities between 99.9% and 100.0% (no false positive results observed), PPV between 99.9% and 100.0% and NPV between 96.1% and 100.0%. In the event of low or very low viral loads (Ct> 33), the sensitivity of the RDT SIENNA™ COVID-19 Antigen Rapid Test Cassette (Nasopharyngeal Swab) showed reduced analytical performances with 69.6% sensitivity, while its specificity remained high (>99.0%). We herein evaluated the analytical performances of the novel point-of-care Ag-RDT SIENNA™ COVID-19 Antigen Rapid Test Cassette (Nasopharyngeal Swab) by reference to multiplex rRT-PCR for SARS-CoV-2 RNA detection as gold standard in a real-life community setting. In the event of significant viral excretion (i.e., N gene Ct values below 33 by reference rRT-PCR), the study Ag-RDT showed high sensitivity (≥94.0%) and specificity (≥99.0%) for SARS-CoV-2 RNA detection, with excellent concordance, reliability and accuracy with the reference multiplex rRT-PCR, and PPVs and J o u r n a l P r e -p r o o f NPVs above 98.0%. The sensitivity of the study Ag-RDT dropped to 69.6% with low or very low viral shedding (Ct> 33). Taken together, these observations demonstrate that the study Ag-RDT harbored excellent analytical performances, which makes it suitable to be used as point-of-care Ag-RDT in various hospital and non-hospital settings where rapid diagnosis of SARS-CoV-2 is necessary. The study Ag-RDT fulfilled the current World Health Organization (WHO)'s recommendations for a screening Ag-RTD stating that, at minimum, Ag-RDTs would need to correctly identify significantly more cases than they would miss (sensitivity ≥80%) and would have very high specificity This study has several limitations. The date of symptoms onset was unknown. Furthermore, the study included only symptomatic patients with suspect SARS-CoV-2 infection, and therefore asymptomatic patients with a priori lower viral load were not evaluated. In addition, the interpretation of analytical performances for high Ct values must take into account thawing of samples and additional dilution prior to sample deposition, which makes interpretation of results much less reliable at these low Declaration of interest. The authors report no conflicts of interest. The authors alone are responsible for the content and the writing of the paper. ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Field evaluation of a rapid antigen test (Panbio COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis Maximizing confidence in a negative result: Quantitative sample adequacy control COVID-19): interim guidance for rapid antigen testing for SARS-CoV-2 COVID-19: CDC guidance for expanded screening testing to reduce silent spread of SARS-CoV-2 Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2 Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand A coefficient of agreement for nominal scales Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection Van den Bruel A; Cochrane COVID-19 Diagnostic Test Accuracy Group., Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev SARS-CoV-2 Foch Hospital study group. The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis? Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection Sars-CoV-2 Diagnostics Pipeline Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests MD: US Department of Health and Human Services, Food and Drug Administration Fast coronavirus tests: what they can and can't do Implementing COVID-19 (SARS-CoV-2) Rapid Diagnostic Tests in Sub-Saharan Africa: A Review. Front Med (Lausanne) Viral cultures for COVID-19 infectious potential assessment -a systematic review Ordonnance n° 2010-49 du 13 janvier 2010 relative à la biologie médicale Arrêté du 16 octobre 2020 modifiant l'arrêté du 10 juillet 2020 prescrivant les mesures générales nécessaires pour faire face à l'épidémie de covid-19 dans les territoires sortis de l'état d'urgence sanitaire et dans ceux où il a été prorogé -Légifrance JORF Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit The measurement of observer agreement for categorical data Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening. Sci Adv Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards Immunologic testing for SARS-CoV-2 infection from the antigen perspective Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms Making sense of rapid antigen testing in SARS-CoV-2 diagnostics Rethinking Covid-19 Test Sensitivity -A Strategy for Containment Antigen Rapid Immunoassay for Diagnosis of COVID-19 in the Emergency Department Cochrane corner: rapid point-of-care antigen and molecular-based tests for the diagnosis of COVID-19 infection Two-sided confidence intervals for the single proportion: comparison of 362 seven methods Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting Detection technologies and recent developments in the diagnosis of COVID-19 infection Challenges of SARS-CoV-2 prevention in flights, suggested solutions with potential on-site diagnosis resembling cancer biomarkers and urgency of travel medicine Limits and Opportunities of SARS-CoV-2 Antigen Rapid Tests: An Experienced-Based Perspective. Pathogens Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis Types of Assays for SARS-CoV-2 Testing: A Review Avis du 25 septembre 2020 de la Société Française de Microbiologie (SFM) relatif à l'interprétation de la valeur de Ct (estimation de la charge virale) obtenue en cas de RT-PCR SARS-CoV-2 positive sur les prélèvements cliniques réalisés à des fins diagnostiques ou de dépistage Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread? Evaluation of a rapid antigen test (Panbio COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients SARS-CoV-2 detection, viral load and infectivity over the course of an infection Comparative evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immune-assays Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low-and middle-income countries Comparison of Rapid Antigen Tests for COVID-19. Viruses Index for rating diagnostic tests Effect of multiple cycles of freeze thawing on the RNA quality of lung cancer tissues Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients Factors associated with asymptomatic infection in health-care workers with SARS-CoV-2 infection in Wuhan, China: a multi-center retrospective cohort study SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients Cycle threshold; FN: False negative; FP: False positive; NPV: Negative predictive value; PPV: Positive predictive value; rRT-PCR: real-time reverse transcriptionpolymerase chain reaction The authors are grateful to T&D Diagnostics Canada Pvt. Ltd., Halifax, Canada, for providing for the tests for the study. 24 100 .0] § Nasopharyngeal samples were collected with a flocked swab, then discarded in 1 ml of physiological saline, and further stored frozen at -80 ° C before reuse; a All 50 swab samples negative by reference rRT-PCR were found negative by the test SIENNA™ COVID-19 Antigen Rapid Test Cassette (Nasopharyngeal Swab); the values of TN and FN were 50 and 0, respectively; b Agreement = TP + TN / TP+FP+TN+FN, expressed in percentage; c The Cohen's  coefficient calculation was used to estimate the concordance (Cohen, 1960)